APA

Yoo D. H., Hrycaj P., Miranda P., Ramiterre E., Piotrowski M., Shevchuk S., Kovalenko V., Prodanovic N., Abello-Banfi M., Gutierrez-Ureña S., Morales-Olazabal L., Tee M., Jimenez R., Zamani O., Lee S. J., Kim H., Park W. & Müller-Ladner U. (20131126). A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study. : Annals of the rheumatic diseases.

Chicago

Yoo Dae Hyun, Hrycaj Pawel, Miranda Pedro, Ramiterre Edgar, Piotrowski Mariusz, Shevchuk Sergii, Kovalenko Volodymyr, Prodanovic Nenad, Abello-Banfi Mauricio, Gutierrez-Ureña Sergio, Morales-Olazabal Luis, Tee Michael, Jimenez Renato, Zamani Omid, Lee Sang Joon, Kim HoUng, Park Won and Müller-Ladner Ulf. 20131126. A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study. : Annals of the rheumatic diseases.

Harvard

Yoo D. H., Hrycaj P., Miranda P., Ramiterre E., Piotrowski M., Shevchuk S., Kovalenko V., Prodanovic N., Abello-Banfi M., Gutierrez-Ureña S., Morales-Olazabal L., Tee M., Jimenez R., Zamani O., Lee S. J., Kim H., Park W. and Müller-Ladner U. (20131126). A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study. : Annals of the rheumatic diseases.

MLA

Yoo Dae Hyun, Hrycaj Pawel, Miranda Pedro, Ramiterre Edgar, Piotrowski Mariusz, Shevchuk Sergii, Kovalenko Volodymyr, Prodanovic Nenad, Abello-Banfi Mauricio, Gutierrez-Ureña Sergio, Morales-Olazabal Luis, Tee Michael, Jimenez Renato, Zamani Omid, Lee Sang Joon, Kim HoUng, Park Won and Müller-Ladner Ulf. A randomised, double-blind, parallel-group study to demonstrate equivalence in efficacy and safety of CT-P13 compared with innovator infliximab when coadministered with methotrexate in patients with active rheumatoid arthritis: the PLANETRA study. : Annals of the rheumatic diseases. 20131126.